Nav: Home

DNA enzyme shuffles cell membranes a thousand times faster than its natural counterpart

June 21, 2018

CHAMPAIGN, Ill. -- A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells.

Researchers at University of Illinois at Urbana-Champaign and the University of Cambridge say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes - and does so by three orders of magnitude. They published their findings in the journal Nature Communications.

"Cell membranes are lined with a different set of molecules on the inside and outside, and cells devote a lot of resources to maintaining this," said study leader Aleksei Aksimentiev, a professor of physics at Illinois. "But at some points in a cell's life, the asymmetry has to be dismantled. Then the markers that were inside become outside, which sends signals for certain processes, such as cell death. There are enzymes in nature that do that called scramblases. However, in some diseases where scramblases are deficient, this doesn't happen correctly. Our synthetic scramblase could be an avenue for therapeutics."

Aksimentiev's group came upon DNA's scramblase activity when looking at DNA structures that form pores and channels in cell membranes. They used the Blue Waters supercomputer at the National Center for Supercomputing Applications at Illinois to model the systems at the atomic level. They saw that when certain DNA structures insert into the membrane - in this case, a bundle of eight strands of DNA with cholesterol at the ends of two of the strands - lipids in the membrane around the DNA begin to shuffle between the inner and outer membrane layers.

See an animation at https://youtu.be/kGgTIFYbUko.

To verify the scramblase activity predicted by the computer models, Aksimentiev's group at Illinois partnered with professor Ulrich Keyser's group at Cambridge. The Cambridge group synthesized the DNA enzyme and tested it in model membrane bubbles, called vesicles, and then in human breast cancer cells.

"The results show very conclusively that our DNA nanostructure indeed facilitates rapid lipid scrambling," said Alexander Ohmann, a graduate student at Cambridge and a co-first author of the paper along with Illinois graduate student Chen-Yu Li. "Most interestingly, the high flipping rate indicated by the molecular dynamics simulations seems to be of the same order of magnitude in experiments: up to a thousand-fold faster than what has previously been shown for natural scramblases."

On its own, the DNA scramblase produces cell death indiscriminately, Aksimentiev said. The next step is to couple it with targeting systems that specifically seek out certain cell types, a number of which have already been developed for other DNA agents.

"We are also working to make these scramblase structures activated by light or some other stimulus, so they can be activated only on demand and can be turned off," Aksimentiev said.

"Although we have still a long way to go, this work highlights the enormous potential of synthetic DNA nanostructures with possible applications for personalized drugs and therapeutics for a variety of health conditions in the future," Ohmann said.
-end-
The U.S. National Science Foundation and the National Institutes of Health supported this work.

Editor's notes: To reach Aleksei Aksimentiev, call 217-333-6495; email aksiment@illinois.edu. To reach Ulrich Keyser, call +44 (0)1223 337272; email ufk20@cam.ac.uk.

The paper "A synthetic enzyme built from DNA flips 107 lipids per second in biological membranes" is available online . DOI: 10.1038/s41467-018-04821-5

University of Illinois at Urbana-Champaign

Related Dna Articles:

A new spin on DNA
For decades, researchers have chased ways to study biological machines.
From face to DNA: New method aims to improve match between DNA sample and face database
Predicting what someone's face looks like based on a DNA sample remains a hard nut to crack for science.
Self-healing DNA nanostructures
DNA assembled into nanostructures such as tubes and origami-inspired shapes could someday find applications ranging from DNA computers to nanomedicine.
DNA design that anyone can do
Researchers at MIT and Arizona State University have designed a computer program that allows users to translate any free-form drawing into a two-dimensional, nanoscale structure made of DNA.
DNA find
A Queensland University of Technology-led collaboration with University of Adelaide reveals that Australia's pint-sized banded hare-wallaby is the closest living relative of the giant short-faced kangaroos which roamed the continent for millions of years, but died out about 40,000 years ago.
More Dna News and Dna Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...